Stanford researchers investigate vaccine hesitancy and show how to better communication about vaccines to encourage acceptance.
Stanford Medicine researchers and others discovered 13 genetic signatures that are closely linked to an increased risk for severe COVID-19.
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
Learning techniques to build resilience lowers the stress and anxiety of raising a child with autism, Stanford research found.
During the COVID-19 pandemic, workers innovated to quickly convert hospital rooms to isolation rooms at Stanford Health Care - ValleyCare.
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
A team of researchers developed a model to simulate potential COVID-19 transmission in elementary and high schools, as well as households.
New research shows that 65% of people in the US will be partially vaccinated by July 4 — but for Hispanic and Black people, rates are lower.
With COVID-19 information evolving daily, the Stanford Health Care pharmacy team had to prepare for the unexpected in its vaccine rollout.
Stanford researchers find that screening all adults in the United States one time for hepatitis B could save money and lives.
A survey shows there's nothing inherent about being a physician that leads to burnout. The problems are long hours and shame about errors.
Stanford Medicine researchers have discovered a drug that could potentially be used to stave off SARS-CoV-2, the virus that causes COVID-19.
Induced pluripotent stem cells share proteins with some cancers. The cells can be used as a vaccine to prevent pancreatic cancers in mice.
Serving chilaquiles, a Mexican breakfast, is one way Stanford Health Care food service workers support hospital workers during the pandemic.
Stanford Medicine researchers discover that the virus behind COVID-19 attacks insulin-producing cells in the pancreas.
As risk factors such as no health insurance and low income accumulate, colorectal cancer patients are less likely to finish chemotherapy.